Literature DB >> 28759007

Generating diversity in human glucocorticoid signaling through a racially diverse polymorphism in the beta isoform of the glucocorticoid receptor.

Shannon D Whirledge1, Christine M Jewell2, Lisa M Barber3, Xiaojiang Xu4, Kevin S Katen2, Stavros Garantziotis5, John A Cidlowski2.   

Abstract

Alternative splicing of the human glucocorticoid receptor gene generates two isoforms, hGRα and hGRβ. hGRβ functions as a dominant-negative regulator of hGRα activity and but also has inherent transcriptional activity, collectively altering glucocorticoid sensitivity. Single-nucleotide polymorphisms in the 3' UTR of hGRβ have been associated with altered receptor protein expression, glucocorticoid sensitivity, and disease risk. Characterization of the hGRβ G3134T polymorphism has been limited to a relatively small, homogenous population. The objective of this study was to determine the prevalence of hGRβ G3134T in a diverse population and assess the association of hGRβ G3134T in this population with physiological outcomes. In a prospective cohort study, 3730 genetically diverse participants were genotyped for hGRβ G3134T and four common GR polymorphisms. A subset of these participants was evaluated for clinical and biochemical measurements. Immortalized human osteosarcoma cells (U-2 OS), stably transfected with wild-type or G3134T hGRβ, were evaluated for receptor expression, stability, and genome-wide gene expression. Glucocorticoid-mediated gene expression profiles were investigated in primary macrophages isolated from participants. In a racially diverse population, the minor allele frequency was 74% (50.7% heterozygous carriers and 23.3% homozygous minor allele), with a higher prevalence in Caucasian non-Hispanic participants. After adjusting for confounding variable, carriers of hGRβ G3134T were more likely to self-report allergies, have higher serum cortisol levels, and reduced cortisol suppression in response to low-dose dexamethasone. The presence of hGRβ G3134T in U-2 OS cells increased hGR mRNA stability and protein expression. Microarray analysis revealed that the presence of the hGRβ G3134T polymorphism uniquely altered gene expression profiles in U-2 OS cells and primary macrophages. hGRβ G3134T is significantly present in the study population and associated with race, self-reported disease, and serum levels of glucocorticoids. Underlying these health differences may be changes in gene expression driven by altered receptor stability.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28759007      PMCID: PMC5759773          DOI: 10.1038/labinvest.2017.76

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  40 in total

1.  Self-reports of health care utilization compared to provider records.

Authors:  P L Ritter; A L Stewart; H Kaymaz; D S Sobel; D A Block; K R Lorig
Journal:  J Clin Epidemiol       Date:  2001-02       Impact factor: 6.437

2.  Natural glucocorticoid receptor mutants causing generalized glucocorticoid resistance: molecular genotype, genetic transmission, and clinical phenotype.

Authors:  Evangelia Charmandari; Tomoshige Kino; Emmanuil Souvatzoglou; Alessandra Vottero; Nisan Bhattacharyya; George P Chrousos
Journal:  J Clin Endocrinol Metab       Date:  2004-04       Impact factor: 5.958

3.  IL-13Rα2 has a protective role in a mouse model of cutaneous inflammation.

Authors:  Umasundari Sivaprasad; Manoj R Warrier; Aaron M Gibson; Weiguo Chen; Yasuhiro Tabata; Stacey A Bass; Marc E Rothenberg; Gurjit K Khurana Hershey
Journal:  J Immunol       Date:  2010-10-22       Impact factor: 5.422

4.  Glucocorticoid receptor polymorphism affects transrepression but not transactivation.

Authors:  Erica L T van den Akker; Henk Russcher; Elisabeth F C van Rossum; Albert O Brinkmann; Frank H de Jong; Anita Hokken; Huibert A P Pols; Jan W Koper; Steven W J Lamberts
Journal:  J Clin Endocrinol Metab       Date:  2006-05-09       Impact factor: 5.958

5.  The interleukin-13 receptor alpha2 chain: an essential component for binding and internalization but not for interleukin-13-induced signal transduction through the STAT6 pathway.

Authors:  K Kawakami; J Taguchi; T Murata; R K Puri
Journal:  Blood       Date:  2001-05-01       Impact factor: 22.113

6.  Translational regulatory mechanisms generate N-terminal glucocorticoid receptor isoforms with unique transcriptional target genes.

Authors:  Nick Z Lu; John A Cidlowski
Journal:  Mol Cell       Date:  2005-04-29       Impact factor: 17.970

7.  The dominant negative β isoform of the glucocorticoid receptor is uniquely expressed in erythroid cells expanded from polycythemia vera patients.

Authors:  Lilian Varricchio; Elena Masselli; Elena Alfani; Angela Battistini; Giovanni Migliaccio; Alessandro Maria Vannucchi; Wenyong Zhang; Damiano Rondelli; James Godbold; Barbara Ghinassi; Carolyn Whitsett; Ronald Hoffman; Anna Rita Migliaccio
Journal:  Blood       Date:  2011-02-25       Impact factor: 22.113

Review 8.  Glucocorticoid receptor polymorphism in obesity and glucose homeostasis.

Authors:  Agnieszka Majer-Łobodzińska; Joanna Adamiec-Mroczek
Journal:  Adv Clin Exp Med       Date:  2017 Jan-Feb       Impact factor: 1.727

9.  TNF receptor-associated factor 1 expressed in resident lung cells is required for the development of allergic lung inflammation.

Authors:  Michiko K Oyoshi; Paul Bryce; Sho Goya; Muriel Pichavant; Dale T Umetsu; Hans C Oettgen; Erdyni N Tsitsikov
Journal:  J Immunol       Date:  2008-02-01       Impact factor: 5.422

10.  Polymorphisms in the glucocorticoid receptor gene that modulate glucocorticoid sensitivity are associated with rheumatoid arthritis.

Authors:  Manon J M van Oosten; Radboud J E M Dolhain; Jan W Koper; Elisabeth F C van Rossum; Marieke Emonts; Khik H Han; Jacques M G W Wouters; Johanne M W Hazes; Steven W J Lamberts; Richard A Feelders
Journal:  Arthritis Res Ther       Date:  2010-08-21       Impact factor: 5.156

View more
  3 in total

1.  The association of morning serum cortisol with glucose metabolism and diabetes: The Jackson Heart Study.

Authors:  Robin Ortiz; Bjoern Kluwe; James B Odei; Justin B Echouffo Tcheugui; Mario Sims; Rita R Kalyani; Alain G Bertoni; Sherita H Golden; Joshua J Joseph
Journal:  Psychoneuroendocrinology       Date:  2018-12-27       Impact factor: 4.905

2.  Glucocorticoid Receptor Mutations and Hypersensitivity to Endogenous and Exogenous Glucocorticoids.

Authors:  Richard J Santen; Christine M Jewell; Wei Yue; Daniel F Heitjan; Hershel Raff; Kevin S Katen; John A Cidlowski
Journal:  J Clin Endocrinol Metab       Date:  2018-10-01       Impact factor: 5.958

Review 3.  Advances in treatment of glucocorticoid-induced osteoporosis.

Authors:  Emory Hsu; Mark Nanes
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2017-12       Impact factor: 3.243

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.